Last: | $137.32 |
---|---|
Change Percent: | -1.27% |
Open: | $136.69 |
Close: | $137.32 |
High: | $140.29 |
Low: | $136.08 |
Volume: | 1,695,460 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$137.32 | $136.69 | $137.32 | $140.29 | $136.08 | 1,695,460 | 07-26-2024 |
$134.98 | $133.95 | $134.98 | $138.365 | $133.45 | 1,338,851 | 07-25-2024 |
$134.16 | $130.87 | $134.16 | $134.43 | $130.18 | 2,066,682 | 07-24-2024 |
$130.65 | $137.61 | $130.65 | $137.66 | $130.49 | 1,640,805 | 07-23-2024 |
$133.42 | $133.06 | $133.42 | $133.93 | $131.4 | 2,009,368 | 07-22-2024 |
$131.78 | $131.96 | $131.78 | $132.78 | $130.29 | 1,731,443 | 07-19-2024 |
$131.97 | $132.32 | $131.97 | $135.21 | $131.66 | 2,783,526 | 07-18-2024 |
$133.5 | $135.16 | $133.5 | $136 | $133.42 | 1,031,195 | 07-17-2024 |
$136.06 | $131.99 | $136.06 | $136.1899 | $131.595 | 1,064,333 | 07-16-2024 |
$131.01 | $132.01 | $131.01 | $133.14 | $130.775 | 1,015,719 | 07-15-2024 |
$132.23 | $131.17 | $132.23 | $133.4 | $130.64 | 1,477,340 | 07-12-2024 |
$130.82 | $128.8 | $130.82 | $131.535 | $127.8775 | 1,667,172 | 07-11-2024 |
$127.07 | $126.42 | $127.07 | $127.14 | $125.542 | 1,837,330 | 07-10-2024 |
$125.42 | $126.24 | $125.42 | $126.24 | $124.16 | 1,558,888 | 07-09-2024 |
$126.07 | $126.68 | $126.07 | $126.73 | $125.4 | 2,091,058 | 07-08-2024 |
$126.37 | $126.4 | $126.37 | $126.61 | $125.29 | 1,341,656 | 07-05-2024 |
$126.13 | $126.12 | $126.13 | $127.66 | $125.83 | 1,288,210 | 07-04-2024 |
$126.13 | $126.12 | $126.13 | $127.66 | $125.83 | 1,288,210 | 07-03-2024 |
$125.78 | $127.43 | $125.78 | $128.57 | $125.44 | 1,981,143 | 07-02-2024 |
$127.164 | $130.4479 | $127.164 | $131.5409 | $126.8256 | 2,364,844 | 07-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Agilent Technologies Inc. Company Name:
A Stock Symbol:
NYSE Market:
Agilent Technologies Inc. Website:
Expands Agilent’s end-to-end biopharma solutions that accelerate drug discovery, development, and manufacturing Agilent Technologies Inc. (NYSE: A) today announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturin...
2024-07-21 07:07:00 ET At long last, Europe has a space rocket, the Ariane 6, able to compete with SpaceX and its ubiquitous Falcon 9. The Ariane 6 isn't a reusable rocket, it arrived four years later than it was supposed to, and it probably costs about twice as much as a Falcon. But fo...
Agilent Technologies Inc. (NYSE: A) will release financial results for the third quarter of fiscal year 2024 after the stock market closes on Aug. 21. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PDT. To join the listen-only conference call webcast,...